Table 1.
Clinical and physical characteristics of T2DM patients with or without CAD
| Parameters | T2DM | T2DM + CAD | P value |
|---|---|---|---|
| Number of patients (M/F) | 75 (33/42) | 79 (42/37) | NS |
| Age (years) | 63 ± 9 | 63 ± 8 | NS |
| BMI (kg/m2) | 31.4 ± 6.1 | 30.8 ± 6.0 | NS |
| Waist circumference (cm) | 107 ± 16 | 104 ± 13 | NS |
| Time from T2DM diagnosis (years) | 7 ± 6 | 10 ± 9 | 0.01 |
| Arterial hypertension (%) | 93 | 89 | NS |
| Fasting glucose (mmol/L) | 7.3 ± 1.8 | 7.0 ± 2.4 | NS |
| HbA1c % (mmol/L) | 7.2 ± 1.6 (55 ± 17) | 7.1 ± 1.8 (54 ± 19) | NS |
| Current medications (%) | |||
| Insulin | 25 | 29 | NS |
| Metformin | 67 | 84 | 0.02 |
| Sulfonylurea | 29 | 25 | NS |
| ACEi | 58 | 43 | NS |
| Beta-blocker | 63 | 76 | NS |
Data are expressed as mean ± SD.
NS nonstatistically significant, M Male, F Female, BMI body mass index, HbA 1c glycated hemoglobin, ACEi angiotensin converting enzyme inhibitor.